Search by Drug Name or NDC
NDC 51655-0305-26 HYDRALAZINE HYDROCHLORIDE 25 mg/1 Details
HYDRALAZINE HYDROCHLORIDE 25 mg/1
HYDRALAZINE HYDROCHLORIDE is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals, LLC. The primary component is HYDRALAZINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Hydralazine is used to treat high blood pressure. Hydralazine is in a class of medications called vasodilators. It works by relaxing the blood vessels so that blood can flow more easily through the body. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 51655-0305-26Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Hydralazine
Product Information
| NDC | 51655-0305 |
|---|---|
| Product ID | 51655-305_0a204958-c413-05dd-e063-6394a90a4b31 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | HYDRALAZINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | hydralazine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | HYDRALAZINE HYDROCHLORIDE |
| Labeler Name | Northwind Pharmaceuticals, LLC |
| Pharmaceutical Class | Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA086242 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51655-0305-26 (51655030526)
| NDC Package Code | 51655-305-26 |
|---|---|
| Billing NDC | 51655030526 |
| Package | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-305-26) |
| Marketing Start Date | 2020-05-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |